Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Thoracic Neoplasms × Electrocardiography × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Cardiotoxicity 7 Lymphoma, Non-Hodgkin 5 Lymphoma 4 Breast Neoplasms 4 Prostatic Neoplasms 3 Neoplasms 3 Myelodysplastic Syndromes 3 Leukemia 3 Heart Failure 3 Triple Negative Breast Neoplasms 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Multiple Myeloma 2 Lymphoma, B-Cell 2 Lung Neoplasms 2 Leukemia, Myeloid, Acute 2 Hematologic Neoplasms 2 Carcinoma in Situ 2 Burkitt Lymphoma 2 Vulvar Neoplasms 1 Vulvar Diseases 1 Ventricular Dysfunction, Left 1 Uterine Cervical Neoplasms 1 Uterine Cervical Dysplasia 1 Urinary Bladder Neoplasms 1 Thoracic Neoplasms 1 Stomach Neoplasms 1 Smoking 1 Small Cell Lung Carcinoma 1 Sleep Initiation and Maintenance Disorders 1 Recurrence 1

Interventions

Carboplatin 12 Pemetrexed 6 pembrolizumab 5 Paclitaxel 5 osimertinib 4 atezolizumab 4 entinostat 3 durvalumab 3 Erlotinib Hydrochloride 3 Cisplatin 3 selpercatinib 2 pralsetinib 2 camrelizumab 2 apatinib 2 Radiosurgery 2 Injections 2 Bevacizumab 2 130-nm albumin-bound paclitaxel 2 toripalimab 1 taletrectinib 1 sotorasib 1 sintilimab 1 repotrectinib 1 pegylated granulocyte colony-stimulating factor 1 patritumab 1 napabucasin 1 ficlatuzumab 1 exemestane 1 efineptakin alfa 1 cobimetinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03396614 2024-02-28

CROSS SECT

University Medical Center Groningen

Thoracic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡